Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for delivery to breast cancer cell line

Document Type : Research article

Authors

1 Gene Therapy Research Center, Zanjan University of Medical Sciences

2 Biotechnology Research Center, Zanjan University of Medical Sciences

3 Department of Agricultural Manegement,Islamic Azad University, Abhar Branch,Zanjan,Iran.

4 School of Pharmacy, Zanjan University of Medical Sciences

Abstract

Co-delivery approach has been recommended to reduce the amount of each drug and to achieve the synergistic effect for cancer treatment. CUR and SF have antitumor effects, but their application is limited because of their low water solubility and poor oral bioavailability. To improve the bioavailability and solubility of SF and CUR, we performed an innovative co-delivery of SF and CUR with magnetic nanoparticles to endorse SF and CUR maintenance as an effective and promising antitumor drugs. The structure of the synthesized nanocarrieris evaluated by X-ray diffraction, transmission electron microscopy, scanning electron microscopy, vibrating sample magnetometer, dynamic light scattering and Fourier transform infrared spectroscopy. The results revealed that the zeta potential of CUR and SF-loaded NPs were about -15.4 mV and the average sizes were 80.57 nm. They were monodispersed (polydispersity index =0.161±0.016) in water, with high drug-loading capacity and stability. CUR and SF were encapsulated into NPs with loading capacity of 19.32 ± 0.023% and 18.74 ± 0.015% and entrapment efficiency of 83.72 ± 0.14% and 81.20 ± 0.18% respectively. The in-vitro study of SF and CUR loaded PEGylated Fe3O4@Au NPs on human breast adenocarcinoma cell line (MCF-7) confirmed that cytotoxicity of SF and CUR can enhance when they are loaded on PEGylated Fe3O4@Au NPs in comparison to free SF and CUR. The results of flow cytometry and real-time PCR shown that this combination can increase therapeutic effects of SF and CUR by apoptosis and necrosis induction as well as inhibiting of migration in MCF-7 cell line.

Keywords

Main Subjects


Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen
LM, Price ER, Rickles RJ, Short Iii GF, Staunton

JE and Jin X. Synergistic drug combinations tend

to improve therapeutically relevant selectivity
. Nat.
biotechnol
. (2009) 27: 659-66.
Sharom JR, Bellows DS and Tyers M. From large

networks to small molecules
. Current opinion in chem.
biol
. (2004) 8: 81-90.
Kaelin WG. The concept of synthetic lethality in the

context of anticancer therapy
. Nat. rev. cancer (2005)
5: 689-98.

Keith CT, Borisy AA and Stockwell BR.

Multicomponent therapeutics for networked systems
.
Nature reviews Drug discov
(2005) 4: 71-8.
Xiao W, Chen X, Yang L, Mao Y, Wei Y and Chen L.

Co-delivery of doxorubicin and plasmid by a novel

FGFR-mediated cationic liposome
. Int. J. Pharm.
(2010) 393: 120-7.

Wiradharma N, Tong YW and Yang Y-Y. Self-

assembled oligopeptide nanostructures for co-delivery

of drug and gene with synergistic therapeutic effect
.
Biomaterials
(2009) 30: 3100-9.
Danafar H, Manjili H and Najafi M. Study of

Copolymer Composition on Drug Loading Efficiency

of Enalapril in Polymersomes and Cytotoxicity of Drug

Loaded Nanoparticles
. Drug Res. (2016) 66: 495-504.
Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach

S and Alexiou C. Drug loaded magnetic nanoparticles

for cancer therapy
. J. Phys. Condens Matter . (2006)
18: S2893.

Zeng L, Ren W, Xiang L, Zheng J, Chen B and Wu

A. Multifunctional Fe 3 O 4–TiO 2 nanocomposites

for magnetic resonance imaging and potential

photodynamic therapy
. Nanoscale (2013) 5: 2107-13.
Nosrati H, Sefidi N, Sharafi A, Danafar H and Kheiri

Manjili H. Bovine Serum Albumin (BSA) coated

iron oxide magnetic nanoparticles as biocompatible

carriersfor curcumin-anticancer drug.
Bioorg. Chem .
(2018) 76: 501-509.

Barreto A, Santiago V, Mazzetto S, Denardin J, Lavín

R, Mele G, Ribeiro M, Vieira IG, Gonçalves T and

Ricardo N. Magnetic nanoparticles for a new drug

delivery system to control quercetin releasing for

cancer chemotherapy
. J. Nanoparticle Res. (2011) 13:
6545-53.

Veiseh O, Gunn JW and Zhang M. Design and

fabrication of magnetic nanoparticles for targeted drug

delivery and imaging
. Adv. Drug Deliv. Rev. (2010) 62:
284-304.

Indira T and Lakshmi P. Magnetic nanoparticles—a

review
. Int. J. Pharm. Sci. Nanotechnol . (2010) 3:
1035-42.

Ho D, Sun X and Sun S. Monodisperse magnetic

nanoparticles for theranostic applications
. Acc. Chem.
Res. Acta
(2011) 44: 875-82.
Gooding JJ and Ciampi S. The molecular level

modification of surfaces: from self-assembled

monolayers to complex molecular assemblies
. Chem.
Soc. Rev
. (2011) 40: 2704-18.
Cui Y-R, Hong C, Zhou Y-L, Li Y, Gao X-M and

Zhang X-X. Synthesis of orientedly bioconjugated

core/shell Fe 3 O 4@ Au magnetic nanoparticles for

cell separation
. Talanta. (2011) 85: 1246-52.
Park H-Y, Schadt MJ, Wang L, Lim I-IS, Njoki PN, Kim

SH, Jang M-Y, Luo J and Zhong C-J. Fabrication of

magnetic core@ shell Fe oxide@ Au nanoparticles for

interfacial bioactivity and bio-separation
. Langmuir.
(2007) 23: 9050-6.

Lyon JL, Fleming DA, Stone MB, Schiffer P and

Williams ME. Synthesis of Fe oxide core/Au shell

nanoparticles by iterative hydroxylamine seeding
.
Nano Lett
. (2004) 4: 719-23.
Goon IY, Lai LM, Lim M, Munroe P, Gooding JJ and

Amal R. Fabrication and dispersion of gold-shell-

protected magnetite nanoparticles: systematic control

using polyethyleneimine
. Chem. Mater. (2009) 21:
673-81.

Danafar H, Kheiri Manjili H, Attari E, and Sharafi A.

Investigation of drug delivery of rattle-structured gold

nanorod-mesoporous silica nanoparticles core–shell

as curcumin carrier and their effect on MCF7 and 4T1

cell lines.
ZUMS J. (2017) 25: 122-34.
Manjili H, Malvandi H, Mousavi M-S and Danafar

H. Preparation and physicochemical characterization

of biodegradable mPEG-PCL coreshell micelles for

delivery of artemisinin
. Pharm. Sci. (2016) 22: 234-43.
Porbarkhordari E, Foladsaz K, Hoseini SH, Danafar H,

Kheiri Manjili HR and Ramazani A. The Hypoglycemic

Effects of an Ethanol Extract of Peganum harmala in

Streptozotocin-Induced Diabetic Rats
. Iran. J. Pharm.
Scie
. (2014) 10: 47-54.
Chen M, Yamamuro S, Farrell D and Majetich

SA. Gold-coated iron nanoparticles for biomedical

applications
. J. Appl. Phys. (2003) 93: 7551-3.
Cho S-D, Li G, Hu H, Jiang C, Kang K-S, Lee Y-S,

Kim S-H and Lu J. Involvement of c-Jun N-terminal

kinase in G2/M arrest and caspase-mediated apoptosis

induced by sulforaphane in DU145 prostate cancer

cells
. Nutr. Ccancer (2005) 52: 213-24.
Sharafi A, Kheiri-Manjili H , Bijania S , Ahmadnia A

and Danafar H. Simple and sensitive high performance

liquid chromatographic (HPLC) method for the

determination of the apigenin from dried powder of

cosmos bipinnatus, apium graveolens and petroselinum

crispum. Iran. J. Pharm. Sci. (2016) 12: 21-32.
Kore AM, Spencer GF and Wallig MA.

Purification of the. omega.-(methylsulfinyl) alkyl

glucosinolate hydrolysis products:1-isothiocyanato-

3-(methylsulfinyl) propane, 1- isothiocyanato-

4-(methylsulfinyl) butane, 4- (methylsulfinyl)

butanenitrile, and 5- (methylsulfinyl) pentanenitrile

from broccoli and Lesquerella fendleri
. J. Agric. Food
Chem
. (1993) 41: 89-95.
DanafarH.Studyofthecompositionofpolycaprolactone/

poly (ethylene glycol)/polycaprolactone copolymer

and drug-to-polymer ratio on drug loading efficiency

of curcumin to nanoparticles.
Jundishapur J. Nat.
Pharm. Produc
. (2017) 12: e34179.
Danafar H, Sharafi A, Kheiri Manjili H and Andalib S.

Sulforaphane delivery using mPEG–PCL co-polymer

nanoparticles to breast cancer cells
. Pharm. Dev.
technol
. (2017) 22: 642-51.
Jin Y, Wang M, Rosen RT and Ho C-T. Thermal

degradation of sulforaphane in aqueous solution
. J.
Agri. Food Chem
. (1999) 47: 3121-3.
Xiao D and Singh SV. Phenethyl isothiocyanate

inhibits angiogenesis in vitro and ex vivo
. Cancer Res.
(2007) 67: 2239-46.

Payne AC, Clarkson GJ, Rothwell S and Taylor G.

Diversity in global gene expression and morphology

across a watercress (Nasturtium officinale R. Br.)

germplasm collection: first steps to breeding
. Hortic.
Res
. (2015) 2.
Singh S and Khar A. Biological effects of curcumin

and its role in cancer chemoprevention and therapy.

Anticancer Agents Med. Chem.
(2006) 6(3): 259-70.
Manjili HK, Malvandi H, Mousavi MS, Attari E

and Danafar H.
In-vitro and in-vivo delivery of
artemisinin loaded PCL–PEG–PCL micelles and

its pharmacokinetic study
. Artif. Cells Nanomed
Biotechnol
. (2017) 1-11.
Dorai T, Cao YC, Dorai B, Buttyan R and Katz AE.

Therapeutic potential of curcumin in human prostate

cancer. III. Curcumin inhibits proliferation, induces

apoptosis, and inhibits angiogenesis of LNCaP prostate

cancer cells
in-vivo. The Prostate (2001) 47: 293-303.
Mirzaee H, Sharafi A, and Sohi HH. In vitro

regeneration and transient expression of recombinant

sesquiterpene cyclase (SQC) in Artemisia annua L.

South African J. Botany.
(2016) 104: 225-31.
Nosrati H, Salehiabar M, Manjili HK, Danafar H

and Davaran S. Preparation of magnetic albumin

nanoparticles via a simple and one-pot desolvation

and co-precipitation method for medical and

pharmaceutical applications.
Int. J. Biol. Macromol.
(2018) 108: 909-15.

Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi B,

and Khar A. Curcumin mediated apoptosis in AK-5

tumor cells involves the production of reactive oxygen

intermediates
. FEBS letters. (1999) 456: 311-4.
Gharebaghi F, Dalali N, Ahmadi E and Danafar H.

Preparation of wormlike polymeric nanoparticles

coated with silica for delivery of methotrexateand

evaluation of anticancer activity against MCF7 cells.

J. Biomater. Appl. (2017) 31: 1305-16

Manjilli H, Danafar H, and Sharafi A. Assessment

of biodegradability and cytotoxicity of mPEG-PCL

diblock copolymers and PCL-PEG-PCL tri block

copolymers on HEK293 cells.
SJKUMS. (2017) 22:
113-25.

Bisht S, Feldmann G, Soni S, Ravi R, Karikar C,

Maitra A and Maitra A. Polymeric nanoparticle-

encapsulated curcumin (“nanocurcumin”): a novel

strategy for human cancer therapy
. J Nanobiotechnol.
(2007) 5: 1-18.

Lao CD, Ruffin MT, Normolle D, Heath DD, Murray

SI, Bailey JM, Boggs ME, Crowell J, Rock CL,

and Brenner DE. Dose escalation of a curcuminoid

formulation
. BMC complementary. altern. Med. (2006)
6: 10.

Bisht K, Wagner K-H and Bulmer AC. Curcumin,

resveratrol and flavonoids as anti-inflammatory, cyto-

and DNA-protective dietary compounds
. Toxicology
(2010) 278: 88-100.

Nomani A, Nosrati H, Manjili HK, Khesalpour L

and Danafar H. Preparation and characterization of

copolymeric polymersomes for protein delivery
. Drug
Res
. (2017) 67: 458-65.
Hoskins C, Min Y, Gueorguieva M, McDougall C,

Volovick A, Prentice P, Wang Z, Melzer A, Cuschieri A

and Wang L. Hybrid gold-iron oxide nanoparticles as a

multifunctional platform for biomedical application
. J.
nanobiotechnol
. (2012) 10: 27.
Khoee S and Kavand A. A new procedure for

preparation of polyethylene glycol-grafted magnetic

iron oxide nanoparticles
. J. Nanostruct. Chem. (2014)
4: 1-6.

Kumagai M, Sarma TK, Cabral H, Kaida S, Sekino

M, Herlambang N, Osada K, Kano MR, Nishiyama N

and Kataoka K. Enhanced
in vivo Magnetic Resonance
Imaging of Tumors by PEGylated Iron–Oxide–Gold

Core–Shell Nanoparticles with Prolonged Blood

Circulation Properties
. Macromolr. Rapid commun .
(2010) 31: 1521-8.

Juge N, Mithen R and Traka M. Molecular basis for

chemoprevention by sulforaphane: a comprehensive

review
. Cell. Mol. Life Sci . (2007) 64: 1105-27.
Izadi A, Manjili HK, Ma’mani L, Moslemi E and

Mashhadikhan M. Sulforaphane Loaded PEGylated

Iron Oxide-Gold Core Shell Nanoparticles: A

Promising Delivery System for Cancer Therapy
. Am.
Int. J. Contemp. Sci. Res
. (2015) 2: 84-94.
Danafar H. Applications of copolymeric nanoparticles

in drug delivery systems.
Drug Res. (2016) 66(10):
506-519.

Fischer AH, Jacobson KA, Rose J and Zeller R.

Hematoxylin and eosin staining of tissue and cell

sections
. CSH Protoc. (2008) 1: 4986.
Moore RG, Granai C, Gajewski W, Gordinier M and

Steinhoff MM. Pathologic evaluation of inguinal

sentinel lymph nodes in vulvar cancer patients: a

comparison of immunohistochemical staining versus


ultrastaging with hematoxylin and eosin staining .
Gynecol. oncol
. (2003) 91: 378-82.
Smolensky ED, Neary MC, Zhou Y, Berquo TS

and Pierre VC. Fe
3O4@ organic@ Au: core–shell
nanocomposites with high saturation magnetisation

as magnetoplasmonic MRI contrast agents
. Chem.
Commun(camb).
(2011) 47(7): 2149-51.
Leslie-Pelecky DL and Rieke RD. Magnetic properties

of nanostructured materials
. J. Chem. Mater. (1996) 8:
1770-83.

Tartaj P, del Puerto Morales M, Veintemillas-

Verdaguer S, Gonzalez-Carreno T and Serna CJ. The

preparation of magnetic nanoparticles for applications

in biomedicine
. J. Phys. D Appl. Phys . (2003) 36:
R182.

Choi S, Lew KL, Xiao H, Herman-Antosiewicz A,

Xiao D, Brown CK and Singh SV. D, L-Sulforaphane-

induced cell death in human prostate cancer cells is


regulated by inhibitor of apoptosis family proteins and

Apaf-1
. Carcinogenesis (2007) 28: 151-62.
Park SY, Kim GY, Bae S-J, Yoo YH and Choi

YH. Induction of apoptosis by isothiocyanate

sulforaphane in human cervical carcinoma HeLa and

hepatocarcinoma HepG2 cells through activation of

caspase-3
. Oncol. Rep . (2007) 18: 181-7.
Zhou L, Duan X, Zeng S, Men K, Zhang X, Yang L

and Li X. Codelivery of SH-aspirin and curcumin

by mPEG-PLGA nanoparticles enhanced antitumor

activity by inducing mitochondrial apoptosis
. Int. j.
nanomed
. (2015) 10: 5205.
Danafar H, Sharafi A, Askarlou S and Manjili HK.

Preparation and characterization of PEGylated iron

oxide-gold nanoparticles for delivery of sulforaphane

and curcumin
. Drug Res . (2017) 67: 698-704.